The electronic package leaflet (ePL) pilot project, launched on 1 January 2022 through cooperation between the medicines agencies of Estonia, Latvia and Lithuania, the Estonian Society of Hospital Pharmacists and marketing authorisation holders, was initially planned for two years. From 1 January 2024, the project was extended until the end of 2026. From the same date, marketing authorisation holders were also able to apply to the Estonian State Agency of Medicines for an exemption from including a printed package leaflet in the packaging of medicinal products supplied through community pharmacies but administered by healthcare professionals, in addition to hospital medicines.
The European Commission recognises the value of the experience gained by the Baltic States for the further digitalisation of medicinal product information across the EU and has agreed to the continuation of the project beyond the end of 2026.
The project will continue without interruption until the new EU Pharmaceutical Directive has been transposed into national law and becomes applicable in the Member States.
Further information on the transition to electronic product information (ePI) is available on the European Medicines Agency's website.
Up to date, approved medicinal product information, including package leaflets, is available in the Estonian State Agency of Medicines' Register of Medicinal Products. At the same time, it is important to ensure that every patient can access medicinal product information in the way that best suits their needs.
- A list of medicinal products distributed in Estonia with an electronic package leaflet can be found HERE.
- A list of medicinal products distributed in Latvia with an electronic package leaflet is available here.
- A list of medicinal products distributed in Lithuania with an electronic package leaflet is available here.
-
Frequently asked questions and answers:
-
Application form for joining the paperless packaging information project is available here.
Last updated: 16.11.2026